Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
595studies shown
Showing 1-12 of 595
Behavioral study icon
RecruitingNCT07111390

Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)

This study is looking at whether 60Hz Intermittent Light Therapy can help people with Depression, Mdd, or Major Depressive Episode. Participants take part in 60Hz Intermittent Light Therapy and complete follow-up assessments.

Remote / online
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 24 Years to 65 Years
Countries
United States
Sponsor
NYU Langone Health
Condition
Depression
Behavioral study icon
RecruitingNCT06976697

Home-Based tDCS Treatment Of Major Depressive Disorder

This study is looking at care and outcomes for people with depression. Some participants may receive Sham treatment instead of the study treatment, and direct benefit is not guaranteed.

Remote / online
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 22 Years to 70 Years
Countries
United States
Sponsor
Sooma Medical Inc
Condition
Depression
Device study icon
RecruitingNCT07217223

Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression: A Home-Based Feasibility and Safety Study

This study is looking at care and outcomes for people with Treatment Resistant Depression or depression. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.

Remote / online
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 85 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Depression
Drug study icon
RecruitingNCT06705478

Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV

This study is recruiting in the United States, in Botswana, in Brazil, .... It focuses on depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 70 Years
Countries
United States, Botswana, Brazil, ...
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Condition
Depression
Drug study icon
RecruitingNCT07139834

Pattern Separation in Major Depressive Disorder

This study is comparing SSRI (escitalopram or sertraline) with placebo for people with depression. Participants receive SSRI (escitalopram or sertraline) or placebo and complete study visits and assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 50 Years
Countries
United States
Sponsor
Jeffrey Miller
Condition
Depression
Drug study icon
RecruitingNCT07196501

Maintenance Effect of NBI-1065845 for depression

This study is recruiting in the United States, in Australia, in Canada, .... It is testing Maintenance Effect of NBI-1065845 for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
United States, Australia, Canada, ...
Sponsor
Neurocrine Biosciences
Condition
Depression
Drug study icon
RecruitingNCT07226661

Study in Adults With Major Depressive Disorder

This study is recruiting in the United States. It focuses on depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Supernus Pharmaceuticals, Inc.
Condition
Depression
Drug study icon
RecruitingNCT06132178

Psilocybin rTMS for Treatment Resistant Depression

This study is comparing Psilocybin with Full dose COMP360 with sham aiTBS rTMS for people with Treatment Resistant Depression, Mdd, depression, or Recurrent Depression. Participants receive Psilocybin or Full dose COMP360 with sham aiTBS rTMS and complete study visits and assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 22 Years to 65 Years
Countries
United States
Sponsor
University of Texas at Austin
Condition
Depression
Behavioral study icon
RecruitingNCT06793397

A Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

This study is recruiting in the United States, in Australia, in the United Kingdom, .... It is testing deuterated Psilocin Analog for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 85 Years
Countries
United States, Australia, United Kingdom, ...
Sponsor
Cybin IRL Limited
Condition
Depression
Behavioral study icon
RecruitingNCT07284667

ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

This study is comparing ACP-211 with placebo for people with depression or depression, Treatment-Resistant. Participants receive ACP-211 or placebo and complete study visits and assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Depression
Drug study icon
RecruitingNCT06966401

NBI-1065845 for depression

This study is recruiting in the United States, in the United Kingdom, in Belgium, .... It is testing NBI-1065845 for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
United States, United Kingdom, Belgium, ...
Sponsor
Neurocrine Biosciences
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.